Japan Lifeline Co., Ltd. Announces Management Changes
December 01, 2023 at 01:10 am EST
Share
Japan Lifeline Co., Ltd. at its meeting held on December 1, 2023 announced to make the following changes to its organizations and personnel, effective on January 1, 2024. The company appointed Takashi Ito, Operating Officer, Senior Manager of Device Department of Arrhythmia Business Unit as Senior Operating Officer, Executive Manager of Arrhythmia Business Unit, Senior Manager of Arrhythmia Sales Department; Hiroki Matsumura, General Manager of CRM Marketing Division of Device Department of Arrhythmia Business Unit as Senior Manager of Device Department of Arrhythmia Business Unit, General Manager of CRM Marketing Division and Ryo Tamayama, General Manager of VS Marketing of VS Department of CVG Business Unit as Senior Manager of VS Department of CVG Business Unit, General Manager of VS Marketing.
Japan Lifeline Co., Ltd. is a Japan-based company mainly engaged in the import, manufacture and sale of cardiac circulators and other medical devices. The Company is mainly engaged in the production of rhythm devices, electrophysiological (EP) and ablations, surgical products and intervention products. The rhythm devices include cardiac pacemakers, implantable cardioverter defibrillator (ICD), cardiac resynchronization therapy defibrillator (CRT-D) and other rhythm devices. The EP and ablations include EP catheters for cardiac arrhythmia examination, ablation catheters for arrhythmia treatment and other EP and ablations. The surgical products include prosthetic heart valves and annuloplasty rings for heart disease surgical treatment, vascular grafts, open stent grafts and stent grafts for aortic disease treatment, as well as other surgical products. The intervention products include balloon catheters, guide wires, penetration catheters and other intervention products.